Vitamin D Supplementation for the Prevention of Cardiovascular Risk

NCT02020694 · clinicaltrials.gov ↗

PHASE4

Phase

COMPLETED

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Obesity
Overweight
Insulin Resistance

Interventions

DRUG: Vitamin D
DRUG: Placebo (for vitamin D)

Sponsor

Fondazione Policlinico Universitario Agostino Gemelli IRCCS